Yun-Hsuan Chen

Yankun Xu, Junzhe Wang, Yun-Hsuan Chen et al.

An accurate and efficient epileptic seizure onset detection can significantly benefit patients. Traditional diagnostic methods, primarily relying on electroencephalograms (EEGs), often result in cumbersome and non-portable solutions, making continuous patient monitoring challenging. The video-based seizure detection system is expected to free patients from the constraints of scalp or implanted EEG devices and enable remote monitoring in residential settings. Previous video-based methods neither enable all-day monitoring nor provide short detection latency due to insufficient resources and ineffective patient action recognition techniques. Additionally, skeleton-based action recognition approaches remain limitations in identifying subtle seizure-related actions. To address these challenges, we propose a novel Video-based Seizure detection model via a skeleton-based spatiotemporal Vision Graph neural network (VSViG) for its efficient, accurate and timely purpose in real-time scenarios. Our experimental results indicate VSViG outperforms previous state-of-the-art action recognition models on our collected patients' video data with higher accuracy (5.9% error), lower FLOPs (0.4G), and smaller model size (1.4M). Furthermore, by integrating a decision-making rule that combines output probabilities and an accumulative function, we achieve a 5.1 s detection latency after EEG onset, a 13.1 s detection advance before clinical onset, and a zero false detection rate. The project homepage is available at: https://github.com/xuyankun/VSViG/

Ziyi Zeng, Yun-Hsuan Chen, Xurong Gao et al.

The impact of repetitive transcranial magnetic stimulation (rTMS) on methamphetamine (METH) users' craving levels is often assessed using questionnaires. This study explores the feasibility of using neural signals to obtain more objective results. EEG signals recorded from 20 METH-addicted participants Before and After rTMS (MBT and MAT) and from 20 healthy participants (HC) are analyzed. In each EEG paradigm, participants are shown 15 METH-related and 15 neutral pictures randomly, and the relative band power (RBP) of each EEG sub-band frequency is derived. The average RBP across all 31 channels, as well as individual brain regions, is analyzed. Statistically, MAT's alpha, beta, and gamma RBPs are more like those of HC compared to MBT, as indicated by the power topographies. Utilizing a random forest (RF), the gamma RBP is identified as the optimal frequency band for distinguishing between MBT and HC with a 90% accuracy. The performance of classifying MAT versus HC is lower than that of MBT versus HC, suggesting that the efficacy of rTMS can be validated using RF with gamma RBP. Furthermore, the gamma RBP recorded by the TP10 and CP2 channels dominates the classification task of MBT versus HC when receiving METH-related image cues. The gamma RBP during exposure to METH-related cues can serve as a biomarker for distinguishing between MBT and HC and for evaluating the effectiveness of rTMS. Therefore, real-time monitoring of gamma RBP variations holds promise as a parameter for implementing a customized closed-loop neuromodulation system for treating METH addiction.

Chengkai Wang, Di Wu, Yunsheng Liao et al.

Methamphetamine dependence poses a significant global health challenge, yet its assessment and the evaluation of treatments like repetitive transcranial magnetic stimulation (rTMS) frequently depend on subjective self-reports, which may introduce uncertainties. While objective neuroimaging modalities such as electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) offer alternatives, their individual limitations and the reliance on conventional, often hand-crafted, feature extraction can compromise the reliability of derived biomarkers. To overcome these limitations, we propose NeuroCLIP, a novel deep learning framework integrating simultaneously recorded EEG and fNIRS data through a progressive learning strategy. This approach offers a robust and trustworthy biomarker for methamphetamine addiction. Validation experiments show that NeuroCLIP significantly improves discriminative capabilities among the methamphetamine-dependent individuals and healthy controls compared to models using either EEG or only fNIRS alone. Furthermore, the proposed framework facilitates objective, brain-based evaluation of rTMS treatment efficacy, demonstrating measurable shifts in neural patterns towards healthy control profiles after treatment. Critically, we establish the trustworthiness of the multimodal data-driven biomarker by showing its strong correlation with psychometrically validated craving scores. These findings suggest that biomarker derived from EEG-fNIRS data via NeuroCLIP offers enhanced robustness and reliability over single-modality approaches, providing a valuable tool for addiction neuroscience research and potentially improving clinical assessments.